Tamer Mohamed Shawky

Prof. Tamer Mohamed Shawky


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Amr NegmAmr Negm
Amr Negm
EMEzat Mersal
Ezat Mersal
ADAmal Dawood
Amal Dawood
AEAmira Abd El-Azim
Amira Abd El-Azim
OHOmar Hasan
Omar Hasan
TSTamer Mohamed Shawky
Tamer Mohamed Shawky
Doxorubicin (DOX) is a potent chemotherapeutic agent used to treat many types of cancer. Its use is limited because of the reported accompanied cardiotoxicity, which is driven by oxidative stress and inflammation. Herin, we explored the cardioprotective impact of reduced glutathione (GSH) against DOX-induced cardiac damage in a mice model and highlighted the dynamic interplay between pro-inflammatory and antioxidant mechanisms, with tissue damage markers and oxidative byproducts. Mice were divided into four groups and administered DOX, GSH, or a combination, and the outcomes were compared to untreated controls. DOX administration caused significant mortality, weight loss, elevated serum markers of cardiac injury (CK-MB and LDH), oxidative stress (MDA and iron), pro-inflammatory cytokines (IL-6, IL-17, and IL-23), and upregulated pro-inflammatory gene expression of STAT-3 and NFκB as well as downregulated gene expression of NRF-2 and HO-1. Histological analysis showed myocardial fibrosis, vacuolization, and apoptosis, as confirmed by a TUNEL assay. Meanwhile, treatment with GSH improved survival rate, attenuated weight loss, and restored cardiac function markers. Furthermore, GSH suppressed oxidative stress and inflammation, modulated gene expression, and declined histopathological damage. These findings demonstrated the multifaceted cardioprotection of GSH through the restoration of redox homeostasis and modulation of the pro- and anti-inflammatory responses. GSH supplementation emerges as a promising adjunct therapy to mitigate DOX-induced cardiotoxicity, offering a strategy to improve cardiac health in cancer patients undergoing doxorubicin chemotherapy.

12 June 2025 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
EKElbadawy A. Kamoun
Elbadawy A. Kamoun
EAEman Abdelaziz
Eman Abdelaziz
SEShahira H. El-Moslamy
Shahira H. El-Moslamy
NANihal Almuraikhi
Nihal Almuraikhi
EMEzat Mersal
Ezat Mersal
ITIbrahim Tantawy
Ibrahim Tantawy
Cancer is one of the major issues faced by the modern health system. Therefore, the development of new, safer and more efficient chemotherapeutics is of prime importance. Traditional cancer therapies, including chemotherapy, are flawed, with off-target and on-target toxicity effects on normal cells; thus, newer strategies to improve cell selective targeting are required. In the present study, a polyvinyl alcohol/sodium alginate membrane as a coumarin–quinoline delivery system was prepared and characterized. It exhibited promising activity against cancer cells with enhanced bioavailability and selectivity. This delivery system is known for its ability to minimize side effects on healthy cells. The coumarin–quinoline hybrid was easily synthesized in high yields via facile reactions of preprepared N1-(7-chloroquinolin-4-yl)propane-1,3-diamine (6) with coumarin-3-carbonyl chloride (3) in the presence of triethylamine at room temperature. The resultant coumarin–quinoline hybrid (CQ) was loaded onto hydrogel membranes made of poly(vinyl alcohol)/sodium alginate and encapsulated using a freeze–thaw method to form physically crosslinked chains. The results of cytotoxicity tests demonstrated that the prepared unloaded hydrogels exhibited cytotoxic effects against Vero cells, unlike control samples (100% cell viability recorded), with reduced cellular viabilities of 64–90%. The hydrogel formula (EA1-4) demonstrated the least cellular viability, while EA1-3 exhibited the highest cellular viability (Vero cells) among the unloaded hydrogels owing to the high SA contents in the membranes. The coumarin–quinoline hybrid-loaded membranes demonstrated a cellular viability of 62–84% owing to increasing coumarin–quinoline hybrid concentrations loaded in the hydrogels (EA2-1, EA2-2, EA2-3, and EA2-4), which decreased the viability of cells compared with CQ-free membranes. Specifically, cellular viability decreased upon increasing CQ concentration; thus, the EA2-4 formula (PVA/sodium alginate, 90 : 10%, 200 mg CQ) showed the highest activity. Statistical analysis of antimicrobial data showed that the EA2-4 formula offered the highest efficacy. After 42 hours of cultivation using the EA2-4 formula, the biofilm reduction percentages for Staphylococcus epidermidis (98.79 ± 2.67%), Staphylococcus aureus (94.96 ± 2.46%), and Bacillus cereus (97.96 ± 0.77%) significantly increased. The findings of this study suggest that the synthesized coumarin–quinoline hybrid-loaded members are good antimicrobial and anticancer biomaterials for versatile medical purposes.